PLURISTEM THERAPEUTICS INC - FORM 10-K - EX-32.1 - EXHIBIT 32.1 - September 11, 2014

Attached files

file filename
EX-10.19 - EXHIBIT 10.19 - PLURISTEM THERAPEUTICS INCexhibit_10-19.htm
EX-10.29 - EXHIBIT 10.29 - PLURISTEM THERAPEUTICS INCexhibit_10-29.htm
EX-10.27 - EXHIBIT 10.27 - PLURISTEM THERAPEUTICS INCexhibit_10-27.htm
EX-10.25 - EXHIBIT 10.25 - PLURISTEM THERAPEUTICS INCexhibit_10-25.htm
EX-10.26 - EXHIBIT 10.26 - PLURISTEM THERAPEUTICS INCexhibit_10-26.htm
EX-10.16 - EXHIBIT 10.16 - PLURISTEM THERAPEUTICS INCexhibit_10-16.htm
EX-23.1 - EXHIBIT 23.1 - PLURISTEM THERAPEUTICS INCexhibit_23-1.htm
EX-10.23 - EXHIBIT 10.23 - PLURISTEM THERAPEUTICS INCexhibit_10-23.htm
EX-31.1 - EXHIBIT 31.1 - PLURISTEM THERAPEUTICS INCexhibit_31-1.htm
EX-10.28 - EXHIBIT 10.28 - PLURISTEM THERAPEUTICS INCexhibit_10-28.htm
EX-10.18 - EXHIBIT 10.18 - PLURISTEM THERAPEUTICS INCexhibit_10-18.htm
EX-31.2 - EXHIBIT 31.2 - PLURISTEM THERAPEUTICS INCexhibit_31-2.htm
EX-32.2 - EXHIBIT 32.2 - PLURISTEM THERAPEUTICS INCexhibit_32-2.htm
EX-10.21 - EXHIBIT 10.21 - PLURISTEM THERAPEUTICS INCexhibit_10-21.htm
EX-10.20 - EXHIBIT 10.20 - PLURISTEM THERAPEUTICS INCexhibit_10-20.htm
EX-10.24 - EXHIBIT 10.24 - PLURISTEM THERAPEUTICS INCexhibit_10-24.htm
EX-10.17 - EXHIBIT 10.17 - PLURISTEM THERAPEUTICS INCexhibit_10-17.htm
EX-10.30 - EXHIBIT 10.30 - PLURISTEM THERAPEUTICS INCexhibit_10-30.htm
EXCEL - IDEA: XBRL DOCUMENT - PLURISTEM THERAPEUTICS INCFinancial_Report.xls
10-K - 10-K - PLURISTEM THERAPEUTICS INCzk1415514.htm
EX-10.22 - EXHIBIT 10.22 - PLURISTEM THERAPEUTICS INCexhibit_10-22.htm
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
 
In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company") for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350,  that, to my knowledge:
 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
Dated: September 11, 2014
 
 
/s/ Zami Aberman
Zami Aberman
Chief Executive Officer
 
 

 

PLURISTEM THERAPEUTICS INC Reports